VGLL3 and rheumatoid arthritis: In RA, a female-biased autoimmune disease, VGLL3 has been shown to modulate the expression of Hippo “off” pathway molecules WWTR1 (TAZ) and AMOTL2 in patient-derived fibroblast-like synoviocytes [37].